Inari Medical, Inc. Stock price

Equities

NARI

US45332Y1091

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 02:32:31 2024-02-21 pm EST 5-day change 1st Jan Change
57.08 USD -1.77% Intraday chart for Inari Medical, Inc. -1.91% -12.00%
Sales 2023 * 494M Sales 2024 * 587M Capitalization 3.35B
Net income 2023 * 2M Net income 2024 * -12M EV / Sales 2023 * 6.04 x
Net cash position 2023 * 363M Net cash position 2024 * 376M EV / Sales 2024 * 5.06 x
P/E ratio 2023 *
1,137 x
P/E ratio 2024 *
-484 x
Employees 1,100
Yield 2023 *
-
Yield 2024 *
-
Free-Float 89.9%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.55%
1 week+1.13%
Current month+2.04%
1 month+1.08%
3 months-0.31%
6 months-9.57%
Current year-10.49%
More quotes
1 week
57.45
Extreme 57.452
59.54
1 month
55.44
Extreme 55.44
59.54
Current year
55.44
Extreme 55.44
66.35
1 year
47.81
Extreme 47.81
71.85
3 years
47.81
Extreme 47.81
127.42
5 years
39.55
Extreme 39.55
127.42
10 years
39.55
Extreme 39.55
127.42
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 Jan. 07
Director of Finance/CFO 65 19-02-28
Chief Tech/Sci/R&D Officer - 19-03-31
Members of the board TitleAgeSince
Director/Board Member 64 11-08-31
Chairman 70 11-08-31
Director/Board Member 57 19-10-31
More insiders
Date Price Change Volume
24-02-21 57.17 -1.62% 161 234
24-02-20 58.11 -0.56% 375,565
24-02-16 58.44 -1.00% 332,881
24-02-15 59.03 +1.36% 570,382
24-02-14 58.24 +1.36% 644,104

Delayed Quote Nasdaq, February 20, 2024 at 04:00 pm EST

More quotes
Inari Medical, Inc. is a medical device company. The Company operates through the development and commercialization of invasive mechanical thrombectomy devices to treat thromboembolism in the venous system. Its product offerings consist of two minimally invasive, catheter-based mechanical thrombectomy systems, which are for venous system and the treatment of the two distinct manifestations of venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE). The Company’s products include ClotTriever System, FlowTriever System, FlowSaver, FlowStasis and FlowTriever 2. The ClotTriever system is a mechanical thrombectomy system designed to core, capture and remove large clots from large vessels and is used to treat DVT and its components include ClotTriever Catheter and ClotTriever Sheath. The Company’s FlowTriever is a large bore catheter-based aspiration and mechanical thrombectomy system designed to remove large clots from large vessels to treat PE.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
58.11 USD
Average target price
80.9 USD
Spread / Average Target
+39.22%
Consensus
1st Jan change Capi.
-10.49% 3 347 M $
+6.79% 10 367 M $
+12.18% 6 948 M $
-7.62% 5 497 M $
+0.54% 5 199 M $
+5.23% 5 007 M $
+10.68% 3 978 M $
+1.36% 2 082 M $
+8.09% 1 952 M $
+5.96% 1 691 M $
Medical Equipment
  1. Stock
  2. Equities
  3. Stock Inari Medical, Inc. - Nasdaq
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer